AARDEX still confirms its leading position in the B2B medication adherence market
AARDEX still confirms its leading position in the B2B medication adherence market, closing steadily more new deals with Pharma Companies, Biotech’s, Excellence Centers and Universities, over 30 countries in 2018.
In the early stages of drug development, as the promise surrounding a new therapy builds, there is a palpable sense of the stakes being raised. And when encouraging findings lead to progress on the clinical trial pathway, those stakes are
The ‘Don’t Miss a Moment’ campaign – another chapter in the story of medication adherence Years from now, in a future where healthcare is far more digitally embedded than it is today, the date of 27 March 2025 might well